| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |